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Abstract
Antibodies against pathogens provide information on exposure to infectious
agents and are meaningful measures of past and present infection. Antibodies
were measured in the plasma of children that are the offspring in a
population-based birth cohort, the Avon Longitudinal Study of Parents and
Children (ALSPAC). Plasma was collected during clinics at age 5, 7, 11 and 15
years. The antigens examined include: fungal ( ;Saccharomyces cerevisiae)
protozoan ( and surface antigen 1 of  ; herpesToxoplasma gondii T. gondii)
viruses (cytomegalovirus, Epstein-Barr virus, herpes simplex virus type 1);
common colds (influenza virus subtypes H1N1 and H3N2); other antigens
(measles); animal (feline herpes virus, Theiler’s virus); bacteria (Helicobacter
); dietary antigens (bovine casein alpha protein, bovine casein betapylori
protein). Alongside the depth of data available within the ALSPAC cohort, this
longitudinal resource will enable the investigation of the association between
infections and a wide variety of outcomes.
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Introduction
Exposure to pathogens can have a profound impact on the health 
of an individual both directly and through connections with other 
diseases1. Studies have linked infectious agents to autoimmune 
diseases (such as with multiple sclerosis2 and type 1 diabetes 
in children3), cancers4, drug hypersensitivity5 and psychiatric 
disorders6. Investigating early life exposure to specific infec-
tious agents is critical to our understanding of the infectious 
aetiologies of diseases of interest and the impact that infection 
may have on development.
The Avon Longitudinal Study of Parents and Children (ALSPAC) 
is a longitudinal birth cohort that recruited pregnant women 
living near Bristol, UK with an estimated delivery date between 
1991 and 19927,8. The study includes extensive phenotypic, 
genetic, epigenetic and metabolomic data on the mothers, 
fathers and children, and follow up is ongoing9.
Antibody levels against a wide variety of infections (some not 
previously measured in humans) have been measured in the 
plasma of ALSPAC children using ELISA, giving an indication 
of whether an individual has been exposed to a specific infec-
tion or bacteria. The infectious agents studied were chosen based 
on previous evidence of association with psychiatric outcomes, 
however they are also of interest in other research domains.
Methods
A 10% subsample of the ALSPAC cohort (known as “Children 
in Focus”) were invited to attend research clinics in the early 
years of the study. From the age of 7 the whole cohort were 
invited to take part in research clinic assessments.
Blood samples used were taken during the following ALSPAC 
clinics: 5 years (“Children in Focus” clinic) collected between 
July 1997 and March 1998; 7 years (“Focus @ 7” clinic) 
collected between September 1998 and October 2000; 11 
years (“Focus 11 +” clinic) collected between January 2003 
and January 2005; 15 years (“TeenFocus 3” clinic) collected 
between October 2006 and November 2008.
Whole blood from each clinic was processed by centrifuging 
at 3500rpm, 4–5°C for 10 minutes. Plasma was subsequently 
aliquoted and stored temporarily at -20°C before long term 
storage at -70/80°C. For samples collected at 15 years plasma 
was immediately stored at -70/80°C. Samples remained frozen 
until plated out into 96 well plates for analysis, apart from a 
subset of samples within the 7 years and 15 years clinics which 
had undergone 1 previous freeze/thaw cycle before plating.
All available EDTA plasma samples from the 5 years, 7 years 
and 15 years clinics were plated out. For the 15 years clinic if 
an EDTA plasma sample was not available from an individual 
a heparin plasma sample was used if one was available. Only 
heparin plasma samples were collected at the 11 years clinic 
and therefore plated out for this time point. If an individual 
had plasma available from multiple clinics these were aliq-
uoted into the same 96 well plate. Following plating out samples 
were refrozen before analysis. IgG antibody titers (IgA for Sac-
charomyces cerevisiae) specific for the antigen of the infection 
of interest in the plasma of ALSPAC children were measured 
by ELISA using methods derived from those which have been 
previously described10. Briefly microtiter plates coated with 
antigens were reacted sequentially with a dilution of human 
plasma, enzyme labelled anti-human IgG and enzyme substrate 
with each step separated by plate washing. The amount of 
colour generated by the ensuing enzyme-substrate reaction was 
measured by a microplate colourimeter. For some analyses the 
measured signal was converted to a standardized score with a 
mean of 2 and a standard deviation of 1 for each plate. The antigens 
used for the assays are displayed in Supplementary Table 1. 
These results were amalgamated into a dataset in RStudio 
(R-3.4.1) and saved to Stata format.
Dataset
The antigens examined are the following: fungal (S. cerevisiae); 
protozoan (Toxoplasma gondii and surface antigen 1 (SAG1) 
of T. gondii); herpes viruses (cytomegalovirus (CMV), Epstein-
Barr virus (EBV), herpes simplex virus type 1 (HSV-1)); 
common colds (influenza virus subtypes H1N1 and H3N2); 
other antigens (measles); animal (feline herpes virus, Theil-
er’s virus); bacteria (Helicobacter pylori); dietary antigens 
(bovine casein alpha protein (α-casein), bovine casein beta protein 
(β-casein)).
The ALSPAC plasma samples measured were taken at four 
ages: 5, 7, 11 and 15 years. The numbers of measures available 
at each time point for a specific antigen are shown in Table 1. 
Differences in antibody titer reflect infection history and pro-
viding information on past or present exposure to infectious 
agents. Across the time points, 13909 samples were analysed 
from 7509 individuals in total (of note: not everyone has been 
measured at all time points). For each infection three types of 
measure are provided: the optical density measure read directly 
from the ELISA plate; the ratio to standards derived from the 
standards measured on each plate; a standardised z-score for 
each ratio to standard measure (ratio to standard minus the 
mean ratio to standard then divided by the standard deviation 
per plate, plus 2). Across the time points, samples were ran-
domly assigned for the antibodies measured. The combination 
of the number of individuals with antibody titer measures across 
the four time points are shown in the Venn diagrams in Figure 1 
and Supplementary Table 2. This helps to demonstrate the 
breadth and depth of longitudinal research that is possible with 
the dataset in terms of power.
The source of the antigens used for the measurement of anti-
bodies to CMV, T. gondii, HSV-1, and measles in a subset of 
samples (968 samples from 513 individuals) were somewhat 
different from the antigens used in subsequent studies. These 
samples were also measured for the whole casein antigen (a 
mixture of α-casein and β-casein) which is different from the 
distinct α-and β-casein used in the subsequent studies. It is 
therefore recommended to analyse the results of this subset 
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Table 1. Number of measures of a specific infection (with mean age in months and percentage female) available from each 
ALSPAC clinic. Blood samples were taken from ALSPAC participants during clinics at ages: 5 years (“Children in Focus” clinic); 7 
years (“Focus @ 7” clinic); 11 years (“Focus 11 +” clinic); 15 years (“TeenFocus 3” clinic). Antibody levels against a wide variety of 
infections have been measured in the plasma of ALSPAC children using ELISA. This table details the numbers of individuals measured 
at each time point for a specific antigen.
ALSPAC clinic N (mean age in months [sd]; % female)
Antigen 5 year clinic 7 year clinic 11 year clinic 15 year clinic Total N
Total samples sent 
over
594 
(61.87 [0.77]; 43.1%)
5367 
(90.49 [3.91]; 48.46%)
4632 
(140.92 [2.88]; 51.19%)
3316 
(185.04, [3.1]; 50.87%) 13,909
Saccharomyces 
cerevisiae 
39 
 (61.79 [0.7]; 43.59%)
357 
(90.4 [3.74]; 51.26%)
329 
(140.62 [2.73]; 55.02%)
243 
(185.11, [3.03]; 53.91%) 968
Toxoplasma gondii 555  (61.88 [0.78]; 43.06%)
5010 
(90.49 [3.92]; 48.26%)
4303 
(140.94 [2.89]; 50.89%)
3073 
(185.04, [3.11]; 50.63%) 12,941
SAG1 protein domain 138  (61.8 [0.67]; 39.86%)
1228 
(90.38 [3.87]; 46.91%)
1057 
(141 [2.92]; 48.82%)
745 
(185.16, [3.27]; 46.71%) 3168
Cytomegalovirus 555 (61.88 [0.78]; 43.06%)
5010 
(90.49 [3.92]; 48.26%)
4303 
(140.94 [2.89]; 50.89%)
3073 
(185.04, [3.11]; 50.63%) 12,941
Epstein-Barr virus 555 (61.88 [0.78]; 43.06%)
5010 
(90.49 [3.92]; 48.26%)
4303 
(140.94 [2.89]; 50.89%)
3073 
(185.04, [3.11]; 50.63%) 12,941
Herpes simplex virus 1 66 (61.82 [0.84]; 50%)
683 
(90.63 [3.97]; 49.63%)
592 
(140.83 [2.91]; 52.2%)
419 
(184.91, [3.09]; 53.46%) 1760
Influenza virus 
subtype H1N1
66 
(61.82 [0.84]; 50%)
683 
(90.63 [3.97]; 49.63%)
592 
(140.83 [2.91]; 52.2%)
419 
(184.91, [3.09]; 53.46%) 1760
Influenza virus 
subtype H3N2
66 
(61.82 [0.84]; 50%)
683 
(90.63 [3.97]; 49.63%)
592 
(140.83 [2.91]; 52.2%)
419 
(184.91, [3.09]; 53.46%) 1760
Measles virus 66 (61.82 [0.84]; 50%)
683 
(90.63 [3.97]; 49.63%)
592 
(140.83 [2.91]; 52.2%)
419 
(184.91, [3.09]; 53.46%) 1760
Feline herpes virus 294 (61.84 [0.8]; 43.2%)
2764 
(90.48 [3.91]; 47.5%)
2387 
(140.94 [2.86]; 49.77%)
1674 
(185.1, [3.16]; 49.04%) 7119
Theiler’s virus 66 (61.82 [0.84]; 50%)
683 
(90.63 [3.97]; 49.63%)
592 
(140.83 [2.91]; 52.2%)
419 
(184.91, [3.09]; 53.46%) 1760
Helicobacter pylori 528 (61.88 [0.77]; 42.23%)
4683 
(90.46 [3.9]; 48.3%)
4039 
(140.93 [2.87]; 51.05%)
2897 
(185.06, [3.11]; 50.5%) 12,147
Alpha-casein protein 66 (61.82 [0.84]; 50%)
683 
(90.63 [3.97]; 49.63%)
592 
(140.83 [2.91]; 52.2%)
419 
(184.91, [3.09]; 53.46%) 1760
Beta-casein protein 66 (61.82 [0.84]; 50%)
683 
(90.63 [3.97]; 49.63%)
592 
(140.83 [2.91]; 52.2%)
419 
(184.91, [3.09]; 53.46%) 1760
separately from the other assays. The numbers of measures avail-
able at each time point for a specific antigen in this subset are 
shown in Supplementary Table 3 and the combinations of number 
of individuals with measures are shown in the Venn diagram 
in Supplementary Figure 1.
The distributions of the standardised z-scores of the infections 
at the ALSPAC 7 year clinic are displayed in Figure 2. The 
distributions of infections at other clinic ages are shown in 
Supplementary Figure 2–Supplementary Figure 4. CMV and 
EBV show a bimodal distribution at all ages. To aid in interpre-
tation, cut-offs may be taken for these infections dividing them 
into two categories: ‘positive’ and ‘negative’, or three categories: 
‘positive’, ‘in between’ and ‘negative’. Measles and T. gondii and 
its surface protein SAG1 have normal distributions across the 
samples. In the case of measles this may be due to viral exposure 
through vaccine.
Several animal (zoonotic) viruses have been measured. The 
measure of feline herpes virus and the murine Theiler’s virus 
is novel in humans and both show a distribution with a posi-
tive skew. IgG antibodies to casein proteins, the family of 
proteins in cow’s milk, can mirror an autoimmune response and 
has been associated with gastrointestinal inflammation.
Antibodies against influenza (H1N1 and H3N2) and the bacteria 
H. pylori display a distribution with a large positive skew. The 
yeast S. cerevisiae displays different distribution at different ages.
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Figure 1. Venn diagram of number of individuals with measures of a specific infection at each combination of ALSPAC clinic ages. 
Blood samples were taken from ALSPAC participants during clinics at ages: 5 years (“Children in Focus” clinic); 7 years (“Focus @ 7” clinic); 
11 years (“Focus 11 +” clinic); 15 years (“TeenFocus 3” clinic). Antibody levels against a wide variety of infections have been measured in 
the plasma of ALSPAC children using ELISA. Venn diagrams display the combination of the number of individuals with measures across the 
four time points. Note: EBV, Epstein-Barr virus; CMV, cytomegalovirus; Toxo, Toxoplasma gondii; H1N1, influenza virus subtype H1N1; H3N2, 
influenza virus subtype H3N2; HSV1, herpes simplex virus 1; α-casein, alpha-casein protein; β-casein, beta-casein protein; TV, Theiler’s 
virus.
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Figure 2. Z-score distributions of the different infections at 7 year ALSPAC clinic. Blood samples were taken from ALSPAC participants 
during the clinic at age 7 years (“Focus @ 7” clinic). Antibody levels against a wide variety of infections have been measured in the plasma of 
ALSPAC children using ELISA. Graphs show the distribution of the standardised z-score for the ratio to standard measure (ratio to standard 
minus the mean ratio to standard then divided by the standard deviation per plate, plus 2) for each antigen measured in the plasma taken 
at the 7 year clinic.
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The dataset has excellent longitudinal data over four time points 
in this birth cohort. Due to the deep phenotype and genetic 
data in ALSPAC, this dataset provides the opportunity for a 
wide range of epidemiological and genetic analysis.
Ethical approval and consent
Ethical approval for the study was obtained from the ALSPAC 
Ethics and Law Committee and the Local Research Ethics 
Committees, full details of the approvals obtained are available 
from the study website (http://www.bristol.ac.uk/alspac/research-
ers/research-ethics/).
Written informed consent to take and analyse blood samples 
was obtained from the parents of participating children at 
each clinic visit. Children were invited to give assent where 
appropriate. Study members have the right to withdraw their 
consent for elements of the study or from the study entirely at any 
time.
Data availability
ALSPAC data access is through a system of managed open 
access. The steps below highlight how to apply for access to the 
data included in this data note and all other ALSPAC data. The 
ALSPAC variable codes highlighted in the dataset descriptions 
can be used to specify required variables.
1. Please read the ALSPAC access policy (PDF, 627kB) 
which describes the process of accessing the data and samples 
in detail, and outlines the costs associated with doing so.
2. You may also find it useful to browse our fully searchable 
research proposals database, which lists all research projects 
that have been approved since April 2011.
3. Please submit your research proposal for consideration by 
the ALSPAC Executive Committee using the online process. 
You will receive a response within 10 working days to advise 
you whether your proposal has been approved.
If you have any questions about accessing data, please email 
alspac-data@bristol.ac.uk.
The ALSPAC data management plan describes in detail the 
policy regarding data sharing, which is through a system of 
managed open access.
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Supplementary material
Supplementary File 1. Supplementary Tables (1–3).
Click here to access the data.
Supplementary Figure 1. Venn diagram of number of individuals with measures at each combination of ALSPAC clinic ages for the 
subset of ALSPAC individuals measured using different sources of antigens as compared to main dataset. Blood samples were taken 
from ALSPAC participants during clinics at ages: 5 years (“Children in Focus” clinic); 7 years (“Focus @ 7” clinic); 11 years (“Focus 11 +” 
clinic); 15 years (“TeenFocus 3” clinic). This ALSPAC infection subset contains antibody levels against Toxoplasma gondii, cytomegalovi-
rus, herpes simplex virus 1, measles virus and casein protein (a mixture of casein alpha and casein beta protein) only.
Click here to access the data.
Supplementary Figure 2. Z-score distributions of the different infections at age 5 years. Blood samples were taken from ALSPAC 
participants during the clinic at age 5 years (“Children in Focus” clinic). Antibody levels against a wide variety of infections have been 
measured in the plasma of ALSPAC children using ELISA. Graphs show the distribution of the standardised z-score for the ratio to standard 
measure (ratio to standard minus the mean ratio to standard then divided by the standard deviation per plate, plus 2) for each antigen meas-
ured in the plasma taken at the 5 year clinic.
Click here to access the data.
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Supplementary Figure 3. Z-score distributions of the different infections at age 11 years. Blood samples were taken from ALSPAC 
participants during the clinic at age 11 years (“Focus 11 +” clinic). Antibody levels against a wide variety of infections have been measured 
in the plasma of ALSPAC children using ELISA. Graphs show the distribution of the standardised z-score for the ratio to standard measure 
(ratio to standard minus the mean ratio to standard then divided by the standard deviation per plate, plus 2) for each antigen measured in the 
plasma taken at the 11 year clinic.
Click here to access the data.
Supplementary Figure 4. Z-score distributions of the different infections at age 15 years. Blood samples were taken from ALSPAC 
participants during the clinic at 15 years (“TeenFocus 3” clinic). Antibody levels against a wide variety of infections have been measured 
in the plasma of ALSPAC children using ELISA. Graphs show the distribution of the standardised z-score for the ratio to standard measure 
(ratio to standard minus the mean ratio to standard then divided by the standard deviation per plate, plus 2) for each antigen measured in the 
plasma taken at the 15 year clinic.
Click here to access the data.
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